Terculous mediastinitis developed after surgical treatment of giant chondrosarcoma on chest wall: one case report.
- Author:
Jae Hoon LEE
1
;
Soo Ho YANG
;
Hyuck KIM
;
Won Sang CHUNG
;
Young Hak KIM
;
Chul Burm LEE
;
Jung Ho KANG
;
Heng Ok JEE
Author Information
1. Department of Thoracic and Cardiovascular Surgery, College of Medicine, Hanyang University, Korea.
- Publication Type:Case Report
- Keywords:
chondrosarcoma;
chest wall reconstruction;
tuberculous mediastinitis
- MeSH:
Cartilage;
Chondrosarcoma*;
Clavicle;
Curettage;
Drainage;
Humans;
Mediastinitis*;
Mediastinum;
Middle Aged;
Myocutaneous Flap;
Pectoralis Muscles;
Polypropylenes;
Steel;
Sternum;
Thoracic Wall*;
Thorax*;
Tuberculosis
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
1997;30(3):348-352
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
A 48 year old man, has been suffering from a growing chondrosarcoma of sternum which has deeply invading the anterior mediastinum. He underwent wide resection of the chest wall tumor including a 4 cm free margin of normal tissue on all portions. The tumor was 15 X 16 X 10 cm in size arising from sternum and include both proximal one third of the clavicle and the 1st, 2nd, and 3rd costal cartilages. The resected skeletal defect in the anterior wall was very large after wide resection of the tumor and reconstructed due to paradoxical chest wall movement with sandwich like method of double over lapping Marlex mesh and methylmethacreylate, and steel wires. The soft tissue reconstructive procedure was done with myocutaneous flap transposition use of pectoralis muscle. But the patient go infected with tuberculosis in the mediastinum two months after the operation. We had removed all of previously inserted prosthetics and performed curettage and drainage. Recently we experienced a case with giant chondrosarcoma of the sternum associated with tuberculous mediastinitis. The patient had an uneventful postoperative course and was discharged with adjuvant treatment such as antituberculous medication for 1 year.
